- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04908241
Telerehabilitation With Aims to Improve Lower Extremity Recovery Post-Stroke (TRAIL-RCT) (TRAIL-RCT)
Telerehabilitation With Aims to Improve Lower Extremity Recovery Post-Stroke (TRAIL-RCT): A Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
With an aging population, and survival rates now at 83% in Canada, the number of stroke survivors is expected to reach 720,000 by 2038. While 90% of individuals with stroke return to independent community living, 80% report residual motor impairment, such as loss or limitation in motor control, or mobility limitation. These limitations have profound effects on the ability to perform everyday activities and are associated with substantial economic strain on the healthcare system. Thus, a primary focus of stroke rehabilitation is on the recovery of motor function, walking and balance, using exercise via physical therapy.
The rapid growth in Internet use and personal mobile devices has opened an array of possibilities for stroke survivors to remotely access specialized rehabilitation from their homes and communities (i.e., telerehabilitation). Telerehabilitation interventions have been used effectively for check-in sessions, education, and counselling after stroke, but knowledge of the effectiveness of using telerehabilitation for the delivery of exercise interventions for lower extremity recovery is limited.
The investigators developed the TeleRehabilitation with Aims to Improve Lower Extremity Recovery Post-Stroke (TRAIL) to address the unmet needs for lower extremity rehabilitation after stroke, and the need for accessible rehabilitation in the face of the COVID-19 pandemic. TRAIL is an exercise program designed to promote lower extremity recovery using technology with real-time therapist instruction and guidance. The investigators recently conducted a proof-of-concept, single-group feasibility study of TRAIL (TRAIL-PROOF). From TRAIL-PROOF, there were have no reports of serious adverse events and 100% retention of participants. Preliminary analysis of 32 individuals completed also suggest improvements in the clinical outcomes, including increased lower extremity strength, functional balance, and balance self-efficacy. Thus, from TRAIL-PROOF, it is evident that the TRAIL protocol has potential to improve lower extremity function among community-dwelling adults with stroke experiencing lower extremity impairment. The investigators now propose a full-scaled randomized controlled trial to further study the TRAIL program (TRAIL-RCT).
The objectives for TRAIL-RCT are as follows:
- The primary objective is to compare functional mobility (Timed Up and Go, primary clinical outcome) after 4 weeks of TRAIL to a 4-week attention-controlled education program (EDUCATION) in individuals ≤12 months post-stroke;
The secondary objective is to compare the 4-week TRAIL and EDUCATION programs on secondary outcomes of:
- Lower extremity strength (30-Second Sit-to Stand test);
- Functional balance (Tandem Stand and Functional Reach);
- Motor impairment (Virtual Fugl-Meyer Assessment);
- Balance self-efficacy (Activities-specific Balance Confidence Scale);
The tertiary objective is to compare the 4-week TRAIL and EDUCATION programs on health economic outcomes:
- Health-related quality of life (Stroke Impact Scale, EuroQol-5D-5 Level); and
- Health resources and costs (Health Resource Utilization Questionnaire)
- The quaternary objective is to evaluate the feasibility of a subsequent larger multisite implementation stepped wedge randomized trial of TRAIL using pre-specified criteria related to process, resources, management, and scientific indicators.
It is hypothesized that:
The primary hypothesis is that the 4-week TRAIL program will lead to greater improvement in functional mobility, as measured by the Timed Up and Go, compared to the 4-week EDUCATION program in individuals ≤12 months post-stroke (Objective 1, primary clinical outcome).
The investigators also anticipate that greater improvements will be observed in the secondary clinical outcomes, in the areas of lower extremity muscle strength, motor impairment, functional balance, and balance self-efficacy, following TRAIL compared to EDUCATION (Objective 2).
The tertiary hypothesis is that the TRAIL intervention will demonstrate superior health economic outcomes compared to the EDUCATION group (Objective 3).
The quaternary hypothesis is that the protocol will demonstrate sufficient feasibility (e.g., rates of recruitment/retention, treatment fidelity and adherence, safety, treatment effects) to support a subsequent larger multi-site implementation stepped wedge randomized controlled trial (Objective 4).
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Elise A Wiley, MSc
- Phone Number: (289) 214-1569
- Email: wileye@mcmaster.ca
Study Contact Backup
- Name: Brodie Sakakibara, PhD
- Phone Number: (250) 807-8505
- Email: brodie@mail.ubc.ca
Study Locations
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V6T 1Z4
- Recruiting
- University of British Columbia
-
Contact:
- Elise A Wiley, MSc
- Phone Number: (289) 214-1569
- Email: wileye@mcmaster.ca
-
Contact:
- Brodie Sakakibara, PhD
- Phone Number: (250) 807-8505
- Email: brodie@mail.ubc.ca
-
Principal Investigator:
- Brodie Sakakibara, PhD
-
Principal Investigator:
- Janice Eng, PT/OT PhD
-
Principal Investigator:
- Courtney Pollock, PT PhD
-
-
Halifax
-
Nova Scotia, Halifax, Canada, B3H 4R2
- Recruiting
- Dalhousie University
-
Contact:
- Melanie Dunlop
- Phone Number: 905-473-1401
- Email: melanie.dunlop@nshealth.ca
-
Contact:
- Judy Lugar
- Phone Number: 902-225-6003
- Email: judy@lugar.ca
-
Principal Investigator:
- Marilyn MacKay-Lyons, MScPT PhD
-
-
Manitoba
-
Winnipeg, Manitoba, Canada, R3L 2P4
- Recruiting
- Riverview Health Centre
-
Contact:
- Anuprita Kanitkar
- Phone Number: 204-881-3112
- Email: Anuprita.Kanitkar@umanitoba.ca
-
Contact:
- Olayinka Akinrolie
- Email: akinrolo@myumanitoba.ca
-
Principal Investigator:
- Ruth Barclay, PhD
-
Principal Investigator:
- Sepideh Pooyania, MD FRCPC
-
-
Ontario
-
London, Ontario, Canada, N6C 5J1
- Recruiting
- Parkwood Institute
-
Principal Investigator:
- Robert Teasell, MD FRCP (C)
-
Contact:
- Alexandria Roa Agudelo
- Phone Number: 42570 (519) 646-6100
- Email: alexandria.roaagudelo@sjhc.london.on.ca
-
Contact:
- Arden Lawson, BMSc
- Phone Number: 42570 (519) 646-6100
- Email: arden.lawson@sjhc.london.on.ca
-
Toronto, Ontario, Canada, M5G 2C4
- Recruiting
- University Health Network
-
Contact:
- Olga Yaroslavtseva
- Phone Number: 416-876-4823
- Email: olga.yaroslavtseva@uhn.ca
-
Principal Investigator:
- Mark Bayley, MD FRCPC
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- ≥19 years of age, ≤12 months post-stroke with lower extremity hemiparesis
- Able to walk ≥10 meters with or without a gait aid and without physical assistance of another person
- Can tolerate 50 minutes of activity (including rest breaks)
- Has cognitive-communicative ability to participate, per clinical judgement
- Able to provide consent
- Has a caregiver, friend, or family member available to provide physical support during the assessment sessions
Exclusion Criteria:
- Currently participating in formal in- or out-patient stroke rehabilitation focusing on lower extremity training
- Living in long-term care
- Severe vision or hearing loss
- Significant musculoskeletal or other neurological conditions
- Not medically stable
- Comorbidities (e.g. limb amputation), pain or other symptoms that significantly impact lower extremity function
- Planned surgery that would preclude or affect participation in the protocol
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: TRAIL
TRAIL is a 4-week progressive exercise and self-management intervention for lower extremity recovery delivered by a trained registered physical therapist, in a 2:1 participant-to-therapist ratio.
Each participant grouping will receive two telerehabilitation sessions (60-90 minutes) each week for 4 weeks (total 8-12 hours).
|
Each week has a specific focus for lower extremity rehabilitation: Week 1) Building a base: 8 exercises, 10-15 repetitions x 2-3 sets Week 2) Increasing repetitions: 8 exercises, 15-20 repetitions x 3 sets Week 3) Building exercise tolerance:10 exercises, 15-20 repetitions x 3 sets Week 4) Maximizing repetitions: 10 exercises, 30 seconds as many reps as possible x 2 sets At the end of the second exercise session each week, the therapist and participants work collaboratively to develop an independent exercise action plan to be completed before the first session of the next week. The self-managed plans includes exercises selected from TRAIL, agreed upon by the participant and therapist, that are safe to perform without therapist oversight. The aims of the exercise action plan are to: i) Add exercise volume without using program resources (e.g., therapist time); and ii) Build capacity for self-management for long-term health and well-being after TRAIL has ended. |
|
Active Comparator: EDUCATION
The EDUCATION control arm is a 4-week education program focusing on stroke knowledge and risk factors. It will be delivered by health professionals who have experience working with individuals with stroke, knowledge of chronic disease self-management (e.g. physical or occupational therapists, nurses, kinesiologists), and who have completed study-specific training on the EDUCATION program Participants will receive video conferencing sessions with the same schedule and 2:1 participant-to-coach ratio as TRAIL. Each participant grouping will receive two educational telerehabilitation sessions (60-90 minutes) each week for 4 weeks (total 8-12 hours). |
EDUCATION has a specific focus on: Week 1) What is stroke (e.g., gaining an understanding of the function of the brain, types of stroke and how stroke affects physical function) and introduction to self-management; Week 2) What is self-management; Week 3) Self-management for post-stroke complications (e.g., activities of daily living); Week 4) Self-management for secondary prevention (e.g., blood pressure, diet, medication, stress management). Education therapists will be provided with lesson plans and manuals to be circulated with the participants, and will facilitate the educational session through interactive Powerpoint presentations. In addition, participants will be asked to complete 30-60 minutes of educational homework, which will be discussed at the commencement of the following session. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline Timed Up and Go (TUG) at 4 weeks
Time Frame: Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months
|
Performance walking test to assess functional mobility
|
Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Stroke Impact Scale (SIS)
Time Frame: Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months
|
Stroke specific, self-reported health status measure.
There are 8 domains assessed in this version and each item is rated using a 5-point Likert scale.
The participant rates his/her difficulty completing the task from 1 to 5, where lower scores mean greater difficulty to complete the item.
|
Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months
|
|
Activities-Specific Balance (ABC) Scale
Time Frame: Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months
|
Self-reported questionnaire measuring self-efficacy in performing activities without losing balance.
The ABC Scale consists of 16 questions that require the participant to rate their confidence in performing the activity from 0% to 100%, where higher percentages indicate greater self-efficacy
|
Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months
|
|
Functional Reach
Time Frame: Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months
|
Performance measure to assess balance through maximal forward reach (in cm) from a fixed base
|
Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months
|
|
Modified Virtual Fugl-Meyer Assessment
Time Frame: Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months
|
Performance measure to assess lower extremity impairment
|
Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months
|
|
30 second Sit to Stand
Time Frame: Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months
|
Performance measure used to assess lower extremity strength
|
Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months
|
|
Health Resource Utilization Questionnaire
Time Frame: Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months
|
Health care utilization calculated by assessing health professional visits, admissions to hospital, laboratory tests/ investigations, and use of medications
|
Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months
|
|
Health-related quality of life (EuroQol-5D-5 Level)
Time Frame: Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months
|
A generic preference-based utility instrument composed of 5 domains of health (mobility, self-care, usual activities, pain, anxiety/depression), each with 5 levels (1=no problems, 5=major problems), which is often used to calculate cost-utility
|
Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months
|
|
Tandem Stand
Time Frame: Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months
|
Performance measure to assess balance through holding a tandem stance position (up to 10 seconds; alternate positions: semi-tandem or feet together
|
Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility Indicator: Recruitment Rate
Time Frame: Study Completion (Post-Intervention, immediately following study completion)
|
Number of participants recruited
|
Study Completion (Post-Intervention, immediately following study completion)
|
|
Feasibility Indicator: Retention Rate
Time Frame: Study Completion (Post-Intervention, immediately following study completion)
|
Number of participants with post-intervention data
|
Study Completion (Post-Intervention, immediately following study completion)
|
|
Feasibility Indicator: Perceived Benefit of Telerehabilitation
Time Frame: Post-Intervention (immediately following 4 weeks of intervention)
|
Satisfaction survey administered at the end of post-intervention visit
|
Post-Intervention (immediately following 4 weeks of intervention)
|
|
Feasibility Indicator: Treatment Fidelity
Time Frame: Post-Intervention (immediately following 4 weeks of intervention)
|
Percentage of telerehabilitation sessions attended, exercise completed during telerehabilitation sessions, and self-management sessions completed
|
Post-Intervention (immediately following 4 weeks of intervention)
|
|
Feasibility Indicator: Blinding of Outcome Assessors
Time Frame: Study Completion (Post-Intervention, immediately following study completion)
|
Percentage of outcome assessors remaining blinded to group allocation throughout duration of study
|
Study Completion (Post-Intervention, immediately following study completion)
|
|
Feasibility Indicator: Appropriateness of Randomization Process
Time Frame: Study Completion (Post-Intervention, immediately following study completion)
|
Number of participants per group and baseline differences in outcomes between groups Baseline differences between groups |
Study Completion (Post-Intervention, immediately following study completion)
|
|
Feasibility Indicator: Number of Participants Excluded based on Eligibility Criteria
Time Frame: Study Completion (Post-Intervention, immediately following study completion)
|
Number of individuals excluded from potential participant list (referrals from inpatient stroke rehabilitation and community outreach)
|
Study Completion (Post-Intervention, immediately following study completion)
|
|
Feasibility Indicator: Participant and Assessor Burden
Time Frame: Study Completion (Post-Intervention, immediately following study completion)
|
Duration (measured in minutes) to complete the assessments.
|
Study Completion (Post-Intervention, immediately following study completion)
|
|
Feasibility Indicator: Participant Burden
Time Frame: Study Completion (Post-Intervention, immediately following study completion)
|
Percentages of participants with pre- and post-assessments
|
Study Completion (Post-Intervention, immediately following study completion)
|
|
Feasibility Indicator: Ease of Using Equipment
Time Frame: Study Completion (Post-Intervention, immediately following study completion)
|
Downtime due to technical issues of tablet and video-conferencing platform (measured in minutes)
|
Study Completion (Post-Intervention, immediately following study completion)
|
|
Feasibility Indicator: Safety
Time Frame: Study Completion (Post-Intervention, immediately following study completion)
|
Number of adverse events from the program sessions or assessments
|
Study Completion (Post-Intervention, immediately following study completion)
|
|
Feasibility Indicator: Processing Time
Time Frame: Study Completion (Post-Intervention, immediately following study completion)
|
Time from initial contact to enrolment
|
Study Completion (Post-Intervention, immediately following study completion)
|
|
GENESIS-PRAXY Questionnaire
Time Frame: Baseline Assessment
|
Questionnaire used to assess gender-related measures encompassing gender roles, relations and identity.
A composite score is calculated to determine whether an individual has primarily masculine, neutral or feminine gender characteristics.
|
Baseline Assessment
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Brodie Sakakibara, PhD, University of British Columbia
- Principal Investigator: Ada Tang, PhD, McMaster University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- TRAIL-RCT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infarction
-
Beijing Northland Biotech. Co., Ltd.Not yet recruitingAcute Myocardial Infarction (AMI) | Acute Myocardial Infarction of Anterior Wall | Acute Myocardial Infarction With ST Elevation | Acute Myocardial Infarction With ST Segment Elevation | Acute Myocardial Infarction of Left VentricleChina
-
University Medical Centre LjubljanaCompletedCardiac Arrest | Postresuscitation Syndrome | Myocardial Infarction (ST-Elevation Myocardial Infarction and Non-ST-Elevation Myocardial Infarction)Slovenia
-
Fundacio Privada Mon Clinic BarcelonaMiracor Medical SAWithdrawn
-
Samsung Medical CenterThe Korean Society of CardiologyNot yet recruiting
-
Azienda ULSS 5 PolesanaUniversity of PadovaUnknownMyocardial Infarction, Acute | ST Segment Elevation Myocardial Infarction | Non-ST Elevation Myocardial Infarction (nSTEMI)Italy
-
Stiftung Institut fuer HerzinfarktforschungGlaxoSmithKline; University Hospital Muenster; Klinikum NürnbergCompletedMyocardial Infarction | ST-Elevation Myocardial Infarction | Non-ST-Elevation Myocardial InfarctionGermany
-
Harbin Medical UniversityNot yet recruitingNon-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV)Acute Myocardial Infarction (AMI) | ST-Segment Elevation Myocardial Infarction(STEMI) | Non-ST-Segment Elevation Myocardial Infarction(NSTEMI)China
-
Population Health Research InstituteCanadian Institutes of Health Research (CIHR); Boston Scientific CorporationCompletedST Elevation Myocardial Infarction | Non ST Elevation Myocardial InfarctionUnited States, Spain, Netherlands, Canada, Australia, Serbia, Egypt, Switzerland, Hungary, United Kingdom, France, Czechia, Nepal, North Macedonia
-
Bispebjerg HospitalOdense University Hospital; Zealand University Hospital; Aarhus University Hospital and other collaboratorsActive, not recruitingST Elevation Myocardial Infarction | Acute Myocardial Infarction | Non-ST Elevation Myocardial Infarction (nSTEMI)Denmark
-
Barts & The London NHS TrustUniversity College, London; Queen Mary University of LondonCompletedAcute Myocardial InfarctionSwitzerland, Denmark, United Kingdom
Clinical Trials on TRAIL
-
Centre Hospitalier Universitaire de Saint EtienneTerminated
-
Centre Hospitalier Universitaire de la RéunionJean Monnet University; Hôpital Privé de la Loire- Saint EtienneCompletedInfections | Running | Immune DeficiencyReunion
-
CPTS Paris 8ICUREsearchEnrolling by invitationOccupational StressFrance
-
Portland State UniversityCompletedPregnancy in Adolescence
-
University of ManitobaUnity Health Toronto; University of Toronto; Ontario Agency for Health Protection...UnknownCardiovascular Diseases | Diabetes Mellitus | Cardiovascular Risk FactorCanada
-
Huazhong University of Science and TechnologyCompletedSurgical Procedure, Unspecified | Obstructive JaundiceChina
-
Sichuan Clover Biopharmaceuticals, Inc.Completed
-
Clover Biopharmaceuticals AUS Pty LtdCompletedPeritoneal MalignanciesAustralia
-
Second Affiliated Hospital, School of Medicine,...Ningbo Medical Center Lihuili Hospital; Hangzhou Hospital of Traditional Chinese... and other collaboratorsActive, not recruiting
-
Sichuan Clover Biopharmaceuticals, Inc.TerminatedPeritoneal CarcinomatosisChina